Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Boston Scientific Corp. (BSX) shares rose 1.42% to $43.58, outperforming the broader market which saw declines in the S&P 500 and Dow Jones. This gain ended a four-day losing streak for the stock. While competitors like Abbott Laboratories and Medtronic also saw slight gains, Stryker Corp. performed better with a 3.15% increase. Trading volume was below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Boston Scientific Corp. (BSX) rallied 1.42% to $43.58 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.
The stock's rise snapped a four-day losing streak.
Boston Scientific Corp. closed 60.20% short of its 52-week high of $109.50, which the company achieved on September 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Abbott Laboratories (ABT) rose 0.18% to $100.75, Medtronic PLC (MDT) rose 0.15% to $82.01, and Stryker Corp. (SYK) rose 3.15% to $318.97.
Trading volume (16.4 M) remained 4.1 million below its 50-day average volume of 20.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-23-26 1646ET